Epernicus: Matthew R Ritter, Ph.D.

Matthew R Ritter, Ph.D.

Position:
Head of R&D

EyeCyte, Inc.
Degrees:

Ph.D., Biochemisry and Cell Biology, University of Southern California (Los Angeles, CA)

B.S., Biology, University of California, Irvine (Irvine, CA)
Past Advisors:

Martin Friedlander (as Post Doctoral Fellow)

Francis Markland (as Graduate Student - Ph.D.)
Research:
Honors:
2002-2005 NIH National Research Service Award

Communities:

Matthew Ritter's Genealogy

The Adobe Flash Player plugin (version 8) is required to view the genealogy tree.
Download the plugin here.

Matthew Ritter's Publications (19)

Chapter 6. Ocular models of angiogenesis.
Aguilar E, Dorrell MI, Friedlander D, Jacobson RA, Johnson A, Marchetti V, Moreno SK, Ritter MR, Friedlander M

Methods in enzymology. 2008;444:115-58
Hypertrophy and heart failure in mice overexpressing the cardiac sodium-calcium exchanger.
Roos KP, Jordan MC, Fishbein MC, Ritter MR, Friedlander M, Chang HC, Rahgozar P, Han T, Garcia AJ, Maclellan WR, Ross RS, Philipson KD

Journal of cardiac failure. 2007 May;13(4):318-29
Pathogenesis of infantile haemangioma: new molecular and cellular insights.
Ritter MR, Butschek RA, Friedlander M, Friedlander SF

Expert reviews in molecular medicine. 2007;9(32):1-19
Progenitor cells and retinal angiogenesis.
Friedlander M, Dorrell MI, Ritter MR, Marchetti V, Moreno SK, El-Kalay M, Bird AC, Banin E, Aguilar E

Angiogenesis. 2007;10(2):89-101
Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy.
Ritter MR, Banin E, Moreno SK, Aguilar E, Dorrell MI, Friedlander M

The Journal of clinical investigation. 2006 Dec;116(12):3266-76
T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E, Dorrell MI, Aguilar E, Ritter MR, Aderman CM, Smith AC, Friedlander J, Friedlander M

Investigative ophthalmology & visual science. 2006 May;47(5):2125-34
Myeloid cells in infantile hemangioma.
Ritter MR, Reinisch J, Friedlander SF, Friedlander M

The American journal of pathology. 2006 Feb;168(2):621-8
Three-dimensional in vivo imaging of the mouse intraocular vasculature during development and disease.
Ritter MR, Aguilar E, Banin E, Scheppke L, Uusitalo-Jarvinen H, Friedlander M

Investigative ophthalmology & visual science. 2005 Sep;46(9):3021-6
Recent progress in our understanding of the pathogenesis of infantile hemangiomas.
Friedlander SF, Ritter MR, Friedlander M

Lymphatic research and biology. 2005;3(4):219-25
Functional adult myocardium in the absence of Na+-Ca2+ exchange: cardiac-specific knockout of NCX1.
Henderson SA, Goldhaber JI, So JM, Han T, Motter C, Ngo A, Chantawansri C, Ritter MR, Friedlander M, Nicoll DA, Frank JS, Jordan MC, Roos KP, Ross RS, Philipson KD

Circulation research. 2004 Sep 17;95(6):604-11
Functional effect of contortrostatin, a snake venom disintegrin, on human glioma cell invasion in vitro.
Schmitmeier S, Markland FS, Ritter MR, Sawcer DE, Chen TC

Cell communication & adhesion. 2003 Jan-Feb;10(1):1-16
Identifying potential regulators of infantile hemangioma progression through large-scale expression analysis: a possible role for the immune system and indoleamine 2,3 dioxygenase (IDO) during involution.
Ritter MR, Moreno SK, Dorrell MI, Rubens J, Ney J, Friedlander DF, Bergman J, Cunningham BB, Eichenfield L, Reinisch J, Cohen S, Veccione T, Holmes R, Friedlander SF, Friedlander M

Lymphatic research and biology. 2003;1(4):291-9
Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis.
Ritter MR, Dorrell MI, Edmonds J, Friedlander SF, Friedlander M

Proceedings of the National Academy of Sciences of the United States of America. 2002 May 28;99(11):7455-60
Contortrostatin, a homodimeric disintegrin, actively disrupts focal adhesion and cytoskeletal structure and inhibits cell motility through a novel mechanism.
Ritter MR, Zhou Q, Markland FS

Cell communication & adhesion. 2001;8(2):71-86
Differential regulation of tyrosine phosphorylation in tumor cells by contortrostatin, a homodimeric disintegrin, and monomeric disintegrins echistatin and flavoridin.
Ritter MR, Markland FS

Toxicon : official journal of the International Society on Toxinology. 2001 Feb-Mar;39(2-3):283-9
Contortrostatin activates ERK2 and tyrosine phosphorylation events via distinct pathways.
Ritter MR, Markland FS

Biochemical and biophysical research communications. 2000 Jul 21;274(1):142-8
Contortrostatin, a snake venom disintegrin, induces alphavbeta3-mediated tyrosine phosphorylation of CAS and FAK in tumor cells.
Ritter MR, Zhou Q, Markland FS

Journal of cellular biochemistry. 2000 Jul 19;79(1):28-37
Molecular cloning and functional expression of contortrostatin, a homodimeric disintegrin from southern copperhead snake venom.
Zhou Q, Hu P, Ritter MR, Swenson SD, Argounova S, Epstein AL, Markland FS

Archives of biochemistry and biophysics. 2000 Mar 15;375(2):278-88
Contortrostatin, a homodimeric disintegrin, binds to integrin alphavbeta5.
Zhou Q, Nakada MT, Brooks PC, Swenson SD, Ritter MR, Argounova S, Arnold C, Markland FS

Biochemical and biophysical research communications. 2000 Jan 7;267(1):350-5

Join Epernicus (membership is free)

Epernicus is open to current and former research scientists.

Already a member?
Sign in to view Matthew's full profile.

Matthew R Ritter, Ph.D.

Head of R&D

Matthew Ritter's Genealogy

Matthew Ritter's Publications (19)